Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any sex
- People who have been diagnosed with, or are suspected to have, a type of liver cancer called hepatocellular carcinoma (HCC), based on medical scans
For Group 1 (people with past treatment records — may include historical data):
- People whose HCC was confirmed by a laboratory examination of tissue (pathology)
- People who received a specific type of cancer medication (either a targeted therapy or immunotherapy) in the last 7 years, with at least one scan result from during that treatment available up to 1 January 2025
- People who had a tissue sample (biopsy) taken between 1 January 2018 and 1 January 2025
- People who have leftover tissue stored from a previous biopsy or surgery
- People whose biopsy was taken less than one year before they started their cancer medication
- People who are still alive must be able to sign a consent form allowing their stored tissue and data to be used for research
For Group 2 (people with advanced HCC — new participants):
- People suspected of having HCC based on scans, or whose HCC has come back after previous treatment
- People for whom a tissue biopsy is already planned as part of their standard medical care
- People who, once HCC is confirmed by pathology, would be considered for some form of systemic (whole-body) cancer treatment (confirm with trial site)
- People who are able to sign a consent form for the use of their tissue, blood samples, and data for research
For Group 3 (people with early-stage HCC — new participants):
People suspected of having HCC based on scans, or whose HCC has come back after previous treatment
People for whom surgery to remove the tumour or a procedure to destroy the tumour is already planned as part of their standard medical care
People who are able to sign a consent form for the use of their tissue, blood samples, and data for research
People already taking part in another clinical trial may still be eligible for this study, provided tissue and blood samples can be collected as required (confirm with trial site)
Who may not be able to join:
- People whose liver function or general health is too poor to receive active treatment
- People whose liver cancer has been confirmed by pathology to be a different type — such as a cancer of the bile ducts (cholangiocarcinoma) or cancer that has spread to the liver from elsewhere in the body
- People whose planned treatment is something other than systemic (whole-body) medication or surgery/ablation — for example, those planned for procedures such as TACE, TARE, or a liver transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 016344225
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Spatial orientation; TCR sharing; Antigen identification; Biomarker validation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.